SCHEMBL3625862

SCHEMBL3625862

O=C1Oc2ccccc2CN1c1ccccc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SNRNP200 O75643 1/20 0.50
▸ HTR1A P08908 2/20 0.47
▸ SLC6A2 P23975 2/20 0.47
▸ SLC6A4 P31645 2/20 0.47
▸ SLC6A3 Q01959 2/20 0.47
▸ HTR6 P50406 1/20 0.40
▸ HIF1A Q16665 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ P2RX1 P51575 1/20 0.39
▸ P2RX3 P56373 1/20 0.39
▸ P2RX4 Q99571 1/20 0.39
▸ PDE4B Q07343 1/20 0.38
▸ MAOB P27338 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ LTA4H P09960 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37
▸ PIK3CG P48736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3622244 0.80 ALDH1A1 (0.49) HTR6MAOBMAPTMAPK1ALDH1A1
SCHEMBL3625864 0.80 MAOA (0.44) SLC6A2SLC6A3HIF1AMAOBMAPT
SCHEMBL3626605 0.73 MGLL (0.41) HTR1AHTR6MAOBMAPK1MAOA
SCHEMBL2784147 0.72 NPC1 (0.51) HTR1AMAOBMAPTTDP1MAOA
SCHEMBL2784276 0.70 POLB (0.41) HTR1AHTR6MAPTTDP1ALDH1A1
SCHEMBL27714988 0.69 HTR1A (0.55) SNRNP200HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL2783566 0.68 DRD3 (0.46) MAPTL3MBTL1ALDH1A1
SCHEMBL28519652 0.68 MAPT (0.46) HTR1AMAOBMAPTMAPK1TDP1
SCHEMBL2767899 0.67 TSHR (0.45) HTR1AMAOBMAOAHTT
SCHEMBL7358848 0.66 SNRNP200 (0.51) SNRNP200HTR1ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795251-B2 3,4-dihydro-benzo[e][1,3]oxazin-2-ones NOVARTIS AG (CH) 2010-09-14 — — US disclosed
EP-1874742-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES Novartis AG (CH) 2008-01-09 — — EP disclosed
WO-2006108671-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES NOVARTIS AG (CH) 2006-10-19 — — WO disclosed
Send feedback